20(S)-Ginsenoside Rh2 inhibits hepatocellular carcinoma by suppressing angiogenesis and the GPC3‐mediated Wnt/β‑catenin signaling pathway
Acta Biochimica et Biophysica Sinica · 2024
DOI: 10.3724/abbs.2024038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2024. Verfasst von Linfei Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Affiliated Hospital of Shandong Second Medical University, Weifang 261031, China. Hauptthemen laut MEDLINE: Ginsenosides, Glypicans, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Affiliated Hospital of Shandong Second Medical University, Weifang 261031, China.
- Clinical Research Center, Affiliated Hospital of Shandong Second Medical University, Weifang 261031, China.
Zitieren
APA
Xu, L., Li, J., Hou, N., Han, F., Sun, X., & Li, Q. (2024). 20(S)-Ginsenoside Rh2 inhibits hepatocellular carcinoma by suppressing angiogenesis and the GPC3‐mediated Wnt/β‑catenin signaling pathway. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2024038
Vancouver
Xu L, Li J, Hou N, Han F, Sun X, Li Q. 20(S)-Ginsenoside Rh2 inhibits hepatocellular carcinoma by suppressing angiogenesis and the GPC3‐mediated Wnt/β‑catenin signaling pathway. Acta Biochimica et Biophysica Sinica. 2024. doi:10.3724/abbs.2024038
BibTeX
@article{Xu2024,
author = {Xu, Linfei and Li, Jing and Hou, Ningning and Han, Fang and Sun, Xiaodong and Li, Qinying},
title = {20(S)-Ginsenoside Rh2 inhibits hepatocellular carcinoma by suppressing angiogenesis and the GPC3‐mediated Wnt/β‑catenin signaling pathway},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2024},
doi = {10.3724/abbs.2024038}
}
EUVIMED